EHC Stock Analysis: Buy, Sell, or Hold?
EHC - Encompass Health Corporation Common Stock
$111.07
0.18 (0.16%)
▲
5d:
-1.61%
30d:
+9.55%
90d:
+11.07%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
2d
Get Alerted When EHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: EHC shows positive signals but monitor for confirmation. Market pricing in 0.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: EHC shows positive signals but monitor for confirmation. Market pricing in 0.6% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$149.12
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$92.59
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EHC is currently trading at $111.07, which is considered fair relative to its 30-day fair value range of $104.32 to $113.52. The stock's valuation (Forward PE: 17.0) is in line with its historical norms (16.7). At these levels, the market is pricing in 0.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, EHC is in a uptrend. The price is currently testing key support at $109.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $140.50 (+26.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, EHC is in a uptrend. The price is currently testing key support at $109.04. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $140.50 (+26.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$104.32 -
$113.52
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
73.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.5% below Wall St target ($140.50)
- NEUTRAL: Market pricing in 0.6% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$104.32 -
$113.52
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$109.04
Resistance Level
$117.17
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.99
Wall Street Target
$140.50
(+26.5%)
Revenue Growth (YoY)
9.0%
Earnings Growth (YoY)
30.3%
Profit Margin
10.0%
Valuation Premium vs History
+0.6% premium
PE vs Historical
17.0 vs 16.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.6%
(market-implied from PE analysis)
1-Year Target
$111.74
(+1%)
2-Year Target
$112.41
(+1%)
3-Year Target
$113.08
(+2%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
PE COMPRESSION
$111.14
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 8.9%)
$174.80
(+57%)
Base:
(SPY PE: 17.0, Growth: 8.9%)
$143.28
(+29%)
Bear:
(PE: 14.4, Growth: 8.9%)
$121.78
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 18.99 | Current EPS (TTM): $5.84
Bull Case
$136.53
(+23%)
Analyst growth 11.9%, PE expands to 20.9
Base Case
$124.12
(+12%)
Market implied 11.9%, PE stable at 19.0
Bear Case
$75.41
(-32%)
Severe decline -20.0%, PE contracts to 16.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 2:11 PM ET
Data refreshes hourly during market hours. Next update: 3:11 PM
Data refreshes hourly during market hours. Next update: 3:11 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Edmund Fay
SELL
11937 shares
2026-03-09
Mark J Tarr
SELL
150000 shares
2026-02-11
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 53 HOLD |
